Vertigo, a common clinical syndrome characterized by the illusion of movement, poses a diagnostic and therapeutic challenge for healthcare professionals. This article aims to elucidate the complexities of vertigo and provide a comprehensive clinical approach to its management.
Vertigo is often a symptom of various vestibular disorders. It can be peripheral, originating from the inner ear, or central, resulting from a brain lesion. Distinguishing between these two types is crucial as it significantly influences the treatment strategy and prognosis.
Diagnosis begins with a thorough history and physical examination. Key factors include the duration and frequency of vertigo episodes, associated symptoms, and triggering factors. The Dix-Hallpike maneuver and head impulse test are valuable bedside tests that aid in diagnosing benign paroxysmal positional vertigo and vestibular neuritis, respectively.
While the diagnosis of vertigo is largely clinical, imaging and laboratory tests can help rule out central causes. Magnetic Resonance Imaging (MRI) is preferred for visualizing brainstem and cerebellar lesions, while blood tests can detect underlying metabolic or systemic disorders.
Treatment of vertigo depends on the underlying cause. Peripheral vertigo can often be managed with vestibular suppressants and physical therapy, while central vertigo requires addressing the primary neurological condition. Patient education and reassurance also play a vital role in managing this condition.
Vertigo, while common, remains a complex clinical entity requiring a comprehensive approach for effective management. By understanding its pathophysiology, adopting a systematic diagnostic approach, and tailoring treatment strategies to the underlying cause, healthcare professionals can significantly improve patient outcomes and quality of life.
1.
Talquetamab Combos Show Survival Benefit in r/r Myeloma
2.
From sweetener to cancer fighter? Fermented stevia shows promise in pancreatic cancer study
3.
Year in Review: Non-Small Cell Lung Cancer
4.
FINAL USPSTF RECOMMENDATIONS ON ANXIETY, DEPRESSION, AND SUIICIDAL RISK.
5.
Liposomal Chemo Combination No Better Than Standard Induction in Pediatric AML
1.
Targeted Therapies for Breast Cancer: What’s New?
2.
Ultrasound: A Promising Tool in the Fight Against Malignant Breast Cancer
3.
Adjuvant Atezolizumab in TNBC: What Recent Trials Reveal About Its Role
4.
Revolutionizing Cancer Care: The Transformative Role of AI and Data Science in Oncology
5.
Sorafenib: Understanding the science behind a powerful cancer drug
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
2.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
4.
Common Cancer Myths Debunked
5.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation